Equifax (EFX) EVP Kathryn Walker awarded 1,497 restricted stock units in 2026 grant

Rhea-AI Filing Summary

Walker Kathryn Q reported acquisition or exercise transactions in this Form 4 filing.

Equifax Inc. executive Kathryn Q. Walker received an equity grant of 1,497 shares of common stock-equivalent units under the company’s long-term incentive plan on February 25, 2026, at a stated price of $0.00 per share as a grant/award, not an open-market purchase.

The award consists of restricted stock units that vest 100% on February 25, 2029, aligning compensation with longer-term company performance. After this award, Walker directly holds a total of 3,273 shares or units, which includes accrued dividend equivalent units reinvested in corresponding restricted stock units through the company’s last dividend payment date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Walker Kathryn Q

(Last) (First) (Middle)

1550 PEACHTREE STREET, N.W.

(Street)

ATLANTA GA 30309

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EQUIFAX INC [ EFX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Mkt & Comms Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	02/25/2026		A		1,497	A	$0.0000	3,273(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 25, 2029.

2. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

	/s/Lisa Stockard as Attorney-in-Fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Equifax (EFX) report for Kathryn Q. Walker?

Equifax reported that executive Kathryn Q. Walker received a grant of 1,497 common stock-equivalent units. The award was made at a stated price of $0.00 per share as part of the company’s long-term incentive plan, rather than through an open-market stock purchase.

What type of equity award did Kathryn Q. Walker receive at Equifax (EFX)?

Kathryn Q. Walker received an annual equity grant in the form of restricted stock units. These units are issued under Equifax’s long-term incentive plan and are designed to align executive compensation with the company’s performance over a multi-year period, subject to full vesting in the future.

When do Kathryn Q. Walker’s Equifax (EFX) restricted stock units vest?

The restricted stock units granted to Kathryn Q. Walker vest 100% on February 25, 2029. This single vesting date creates a long-term incentive horizon, encouraging retention and performance over several years before the units convert into fully vested common stock-equivalent shares.

How many Equifax (EFX) shares or units does Kathryn Q. Walker hold after this grant?

Following the reported grant, Kathryn Q. Walker directly holds a total of 3,273 shares or units. This figure includes the newly granted restricted stock units as well as accrued dividend equivalent units that were reinvested in corresponding restricted stock units through Equifax’s most recent dividend payment date.

Does the Equifax (EFX) equity grant to Kathryn Q. Walker include dividend equivalents?

Yes, the holdings disclosed for Kathryn Q. Walker include accrued dividend equivalent units. These units represent dividends that were reinvested into corresponding restricted stock units through Equifax’s last dividend payment date, increasing the total number of units reflected in her direct ownership.

What is Kathryn Q. Walker’s role at Equifax (EFX) related to this Form 4 filing?

In this filing, Kathryn Q. Walker is identified as an officer of Equifax, serving as EVP, Chief Marketing & Communications Officer. The reported equity grant reflects part of her executive compensation structure under the company’s long-term incentive plan, rather than a discretionary stock market trade.